Your browser doesn't support javascript.
loading
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.
Farzad, Niloofar; Barati, Nastaran; Momtazi-Borojeni, Amir Abbas; Yazdani, Mona; Arab, Atefeh; Razazan, Atefeh; Shariat, Sheida; Mansourian, Mercedeh; Abbasi, Azam; Saberi, Zahra; Badiee, Ali; Jalali, Seyed Amir; Jaafari, Mahmoud Reza.
Afiliación
  • Farzad N; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Barati N; c Department of Pharmaceutical Nanotechnology , School of Pharmacy, Mashhad University of Medical Science , Mashhad , Iran.
  • Momtazi-Borojeni AA; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Yazdani M; b Biotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Arab A; c Department of Pharmaceutical Nanotechnology , School of Pharmacy, Mashhad University of Medical Science , Mashhad , Iran.
  • Razazan A; d Nanotechnology Research Center, Department of Medical Biotechnology, Student Research Committee, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Shariat S; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Mansourian M; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Abbasi A; b Biotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Saberi Z; c Department of Pharmaceutical Nanotechnology , School of Pharmacy, Mashhad University of Medical Science , Mashhad , Iran.
  • Badiee A; e Department of Molecular Medicine , School of Advanced Technologies in Medicine, Tehran University of Medical Sciences , Tehran , Iran.
  • Jalali SA; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
  • Jaafari MR; a Nanotechnology Research Center, Pharmaceutical Technology Institute , Mashhad University of Medical Sciences , Mashhad , Iran.
Artif Cells Nanomed Biotechnol ; 47(1): 665-673, 2019 Dec.
Article en En | MEDLINE | ID: mdl-30829072
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Receptor ErbB-2 / Vacunas contra el Cáncer / Nanopartículas / Neoplasias Mamarias Experimentales Límite: Animals Idioma: En Revista: Artif Cells Nanomed Biotechnol Año: 2019 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Receptor ErbB-2 / Vacunas contra el Cáncer / Nanopartículas / Neoplasias Mamarias Experimentales Límite: Animals Idioma: En Revista: Artif Cells Nanomed Biotechnol Año: 2019 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido